BLM and cancer: In addition to identifying gene mutations significantly associated with these clinical features, we also identified novel driver genes, including SPAT1, ANKRD11, ERCC3, RAD50, WRN, BLM, WISP3, CDK8, PAK3, and WEE1, which have not been reported in the Cancer Gene Census (CGC) database.